Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Resensitization to Nivolumab after Intratumoral Chemotherapy in Recurrent Head and Neck Squamous Cell Cancer: A Report of 2 Cases

Abstract : The survival of patients with head and neck squamous cancer with locoregional recurrence is short if salvage surgery or radiation cannot be performed. Systemic chemotherapy based on platinum salts and cetuximab produces only partial and transient responses. Immune checkpoint inhibitors (i.e., nivolumab) lead to a low complete response rate of only about 10%, but in some cases the effects can be long-lasting. Intratumoral chemotherapy (ITC) has been proposed for patients with local recurrence of head and neck squamous cell carcinoma with an objective response rate of 27-50%. However, it often leads to peritumoral tissue necrosis, and the duration of local control is limited. Here, we present 2 patients with head and neck squamous cell cancer whose local recurrences were refractory to intravenous chemotherapy and nivolumab. ITC using nonnecrotizing molecules, associated with nivolumab, led to complete stable local and distant response. ITC seems to trigger tumor resensitization to previously ineffective immunotherapy. This combination deserves an evaluation in the framework of a prospective trial.
Type de document :
Article dans une revue
Liste complète des métadonnées

https://hal-u-picardie.archives-ouvertes.fr/hal-03598660
Contributeur : Laurent Jonchère Connectez-vous pour contacter le contributeur
Soumis le : jeudi 2 juin 2022 - 16:10:13
Dernière modification le : dimanche 4 septembre 2022 - 17:22:28
Archivage à long terme le : : samedi 3 septembre 2022 - 19:50:36

Fichier

507986
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

Collections

Citation

Aline Houessinon, Aurelie Moreira, Jérémie Bettoni, Marine Schoonaker, Chloé Sauzay, et al.. Resensitization to Nivolumab after Intratumoral Chemotherapy in Recurrent Head and Neck Squamous Cell Cancer: A Report of 2 Cases. Case Reports in Oncology, Basel : Karger, 2020, 13 (2), pp.835-842. ⟨10.1159/000507986⟩. ⟨hal-03598660⟩

Partager

Métriques

Consultations de la notice

35

Téléchargements de fichiers

1